Development and characterization of salmeterol xinafoate niosomes for nasal delivery

Indian Journal of Pharmaceutical Education and Research

Volumn 45, Issue 2, 2011, Pages 121-127

  Mouzam, Md Ismail ^a   Dehghan, M H G ^a   Shaikh, Samina M ^a  

^a Y B CHAVAN COLLEGE OF PHARMACY   (India)

Author keywords

Cholesterol; Entrapment efficiency; In vitro drug release; Niosomes; Salmeterol xinafoate; Span60

Indexed keywords

CHOLESTEROL; NIOSOME; SALMETEROL XINAFOATE; SORBITAN STEARATE;

ARTICLE; CONCENTRATION (PARAMETERS); DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MANUFACTURE; DRUG RELEASE; EXCIPIENT COMPATIBILITY; FACTORIAL DESIGN; IN VITRO STUDY; INTRANASAL DRUG ADMINISTRATION; TRANSMISSION ELECTRON MICROSCOPY;

EID: 79958725288     PISSN: 00195464     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Lisbeth Ilium. Nasal drug delivery: New developments and strategies. DDT 2002;7:1184-1189.
2. Behl CR, Pimplaskar HK, Sileno AP, DeMeireles J, Romeo VD. Effects of physicochemical roperties and other factors on systemic nasal drug delivery. Adv Drug DelivRev 1998;29:89-116.
3. Priyanka Arora, Shringi Sharma and Sanjay Garg. Permeability issues in nasal drug delivery. DDT 2002; 7: 967-975.
4. Wermeling DP, Miller JL, Rudy AC. Intranasal delivery, systemic intranasal drug delivery: Concepts and applications. DDT 2002; 2:57-56.
5. Wang F, Jiang X, Lu W. Intranasal delivery of methotrexate to the brain in rats bypassing the blood-brain barrier. DDT 2004;4:48-55.
6. Persyn JT, McDonough J A, Nino JA, Dixon NH, Boland E J. Mucosal delivery of cytotoxic herapeutic agents: Response of rat nasal mucosa to microencapsulated ethopropazine HC1 enantiomer. J Micro 2005; 22: 737-744.
7. Henry Costantino R, Lisbethlllum, Gordon Brandt, Paul Johnson H, Steven Quay C. Intranasal delivery: Physicochemical and therapeutic aspects. Int J Pharm 2007;337:1-24.
8. Elizabeth Hood, Joel Strom A, Michael Vamauker, Inventors; University of South Florida, assignee. Ultrasound enhancement of drug release across non-ionic surfactant membranes. US Patent 292-211.2006 Dec 28.
9. Joseph Schwarz, Michael Weisspapir, Inventors; Colloidal solid lipid vehicle for pharmaceutical use. US Patent 222716Al. 2006Oct5.
10. Schreier H, Bouwstra J. Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery. J Control Rel 1994; 30:1-15.
11. Chengjiu Hu, David Rhodes G. Proniosomes: A Novel Drug Carrier Preparation, Int JPharm 1999; 185:23-35.
12. Vila A, Sanchez A, Evora C, Soriano I, McCallion O, Alonso M J. PLA-PEG particles as nasal protein carriers: the influence of particle size. Int J Pharm 2005; 292: 43-52.
13. Xiaoling Gaoa, Weixing Taoa, Wei Lua, Qizhi Zhanga, Yan Zhangb, Xinguo Jianga, Shouuan Fu. Lectin-conjugated PEG-PL A nanoparticles: Preparation and brain delivery after intranasal administration. Biomaterials 2006; 27:3482-3490.
14. Huang Y and Donovan MD. Large molecule and particulate uptake in the nasal cavity: the effect of size on nasal absorption. Adv Drug Deliv Rev 1998;29:147-155.
15. Vladimir C, Spencer JC. Minimizing matrix effects in the development of a method for the determination of salmeterol in human plasma by LC/MS/MS at low pg/mL concentration levels. Journal of Chromatography B, 2007;856:285-293.
16. Sameer GL, Yi-Ying Yu, Ajay K. Banga. Effects of disintegration-promoting agent, lubricants and moisture treatment on optimized fast disintegrating tablets. Int J Pharm 2009; 365:4-11.
17. Varshney HM, Tanwar YS, Lowalekar R, Rathod KS. Designing and characterization of verapamil hydrochloride niosomes. The Indian Pharmacist 2007; 6: 77-79.
18. Varghese V, Vitta P, Bakshi V, Agarwal S, Pandey S. Niosomes of Primaquine: effect of sorbitan esters (spans) on the vesicular physical characteristics. Indian Drugs 2004;41:101-103.
19. Sakuma S, Sudo R, Suzuki N, Kikuchi H, Akashi M, Ishida Y, Hayashi M. Behavior of mucoadhesive nanoparticles having hydrophilic polymeric chains in the intestine. J Control Rel 2002; 81:281-290.
20. Fuying Cui, Feng Qian, Chunhua Yin. Preparation and characterization of mucoadhesive polymer-coated nanoparticles. Int J Pharm 2006; 316:154-161.
21. Canan Hascicek, Nursin Gonul, Nevin Erk. Mucoadhesive microspheres containing gentamicin sulfate for nasal administration: Preparation and in vitro characterization. 2 Farmaco 2003; 5 8:11-16.
22. Arunothayanun P, Bernard MS, Craig DQM, Uchegbu IF, Florence AT. The effect of processing variables on the physical characteristics of non-ionic surfactant vesicles (niosomes) formed from a hexadecyldiglycerol ether. Int J Pharm 2000; 201:7-14.
23. Sambhaji Pisal, Vijay Shelke, Kakasaheb Mahadik, Shivajirao Kadam. Effect of Organogel Components on In Vitro Nasal Delivery of Propranolol Hydrochloride. AAPS PharmSciTech 2004; 5:1-7.
24. Nasseri B. Effect of cholesterol and temperature on the elastic properties of niosomal membranes. Int J Pharm 2005; 300: 95-101.
25. Agarwal S, Bakshi V, Vitta P, Raghuram AP, Pandey S, Udupa N. Effect of cholesterol content and Surfactant HLB on vesicle properties of niosomes. Indian J Pharm Sci 2004; 1:121-122.
26. Manosroi A, Wongtrakul P, Manosroi J, Sakai H, Sugawara F, Yuasa M, Abe M. Characterization of vesicles prepared with various non ionic surfactants mixed with cholesterol. Colloids Surf B: Biointerfaces 2003;30:129-138.
27. Lopez-Pinto JM, Gonzalez-Rodryguez ML, Rabasco AM. Effect of cholesterol and ethanol on dermal delivery fromDPPC liposomes. Int J Pharm 2005; 298:1-12.
28. Davis SS. Nasal vaccines. Adv Drug Deliv Rev 2001; 51:21-42.
29. Jain CP, Vyas SP, Dixit VK. Niosomal system for delivery of rifampicin to lymphatics. Indian J Pharm S 2006; 5:575-577.